Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ligand Pharm (NQ: LGND ) 79.81 -0.73 (-0.91%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 69,605 Open 79.90 Bid (Size) 71.50 (1) Ask (Size) 93.45 (21) Prev. Close 80.54 Today's Range 79.33 - 81.01 52wk Range 49.24 - 94.57 Shares Outstanding 16,676,532 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults June 18, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Participate in Upcoming Investor Conferences May 23, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Performance YTD +10.37% +10.37% 1 Month -7.87% -7.87% 3 Month +9.16% +9.16% 6 Month +15.12% +15.12% 1 Year +3.26% +3.26% More News Read More 3 Magnificent Growth Stocks to Buy Hand Over Fist May 22, 2024 Via The Motley Fool Topics Economy Exposures Interest Rates 3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off May 20, 2024 Via InvestorPlace Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga Ligand Pharmaceuticals's Earnings: A Preview February 26, 2024 Via Benzinga LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Ligand Reports First Quarter 2024 Financial Results May 07, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement May 07, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Don't Overlook These Top Medical Stocks As Q1 Earnings Approach May 07, 2024 Via Talk Markets Ligand to Report First Quarter 2024 Financial Results on May 7, 2024 April 23, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire 7 Small-Cap Stocks for the Thinking Speculator April 08, 2024 Via InvestorPlace Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference April 08, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™ April 03, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference March 05, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 04, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Why Is Ligand Pharmaceuticals Stock Trading Higher Today? February 27, 2024 Via Benzinga Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday February 27, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 27, 2024 Via Benzinga Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Making Surprising Moves in Tuesday Session February 27, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 27, 2024 Via Benzinga Ligand Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa® February 22, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires February 16, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 February 13, 2024 From Ligand Pharmaceuticals Incorporated Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
